Compound ID | 88
Class: Beta-lactam (cephalosporin)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Broad spectrum activity |
| Institute where first reported: | Cubist Pharmaceuticals (Merck), USA |
| Year first mentioned: | 2013 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |